Patent · US Active

Bivalent SMAC mimetics and the uses thereof

US8202902B2 · kind B2 · utility

3Cited by
4References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 13, 2008
Grant dateJun 19, 2012
Priority date
Expiry dateNov 18, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to bivalent mimetics of Smac which function as inhibitors of Inhibitor of Apoptosis Proteins. The invention also relates to the use of these mimetics for inducing apoptotic cell death and for sensitizing cells to inducers of apoptosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.